A recent study revealed that L-FABP promotes diet-induced fatty liver disease and hepatic steatosis [41], but L-FABP expression was not significantly correlated with clinical pathologic characteristics (including age, sex, grade, invasion, metastasis, and stage) in the present study (Table 2). Here, FABP1 is linked to fatty liver disease.